Tesamorelin 5mg

Description

Concentration – 5 mg per vial

Physical Form – Sterile lyophilized powder (3 mL glass vial)

Product Features –

• Freeze-dried formulation for enhanced shelf life and long-term stability
• Sealed with a durable butyl rubber stopper for multi-dose access without compromising sterility
• Vials are depyrogenated, ETO-sterilized, and finished with a tamper-evident aluminum flip-top for maximum safety and integrity

Research Highlights:-

• GH-Releasing Action:
  Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), clinically shown to stimulate the pituitary gland to produce and release endogenous growth hormone (GH), enhancing IGF-1 levels.
• Fat Reduction in Visceral Areas:
  In FDA-approved clinical trials, Tesamorelin significantly reduced visceral adipose tissue (VAT)—particularly in patients with lipodystrophy—without affecting subcutaneous fat, making it a key agent in metabolic fat redistribution research.
• Improved Lipid Profile & Insulin Sensitivity:
  Studies indicate Tesamorelin helps improve triglyceride levels and may enhance insulin sensitivity, supporting broader applications in metabolic syndrome and type 2 diabetes.
• Cognitive Health Support:
  Emerging data suggests Tesamorelin may have neuroprotective effects by enhancing neurogenesis and reducing brain inflammation, with potential applications in aging-related cognitive decline.
• Muscle Preservation & Performance:
  Through its GH-boosting mechanism, Tesamorelin may support lean muscle retention, improved recovery, and anabolic balance during fat-loss or aging-related muscle wasting.